This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Fresenius Medical Care Affina Gmbh, Fresenius Medical Care Deutschland Gmbh, Mdc Max-Delbruck-Centrum Fur Molekulare Medizin Berlin-Buch. Active years: 1996-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stegelitz, DE (2006 - 2007)
- Berlin, DE (1996 - 2017)
Company Filing History:
2 out of 2 
2 out of 885 
2 out of 2 Years Active: 1996-2017
Title: Inventor Spotlight: Rudolf Kunze
Introduction
Rudolf Kunze is a notable inventor based in Berlin, Germany, with a significant contribution to the field of biochemistry and medicinal sciences. With a total of six patents to his name, Kunze has made advancements that may influence therapeutic approaches in various medical applications.
Latest Patents
Among his latest inventions, Kunze has developed peptides that exhibit binding affinity to an antibody recognizing specific epitopes on adrenoreceptors. Notably, his work includes peptides with an effective dose (ED) of less than 500 nm, particularly around 10 nM, which bind to an extracellular epitope on a human adrenoceptor. The binding of these antibodies prompts an increase in γ-secretase activity, leading to a higher release of β-amyloid molecules. These innovative peptides may play a crucial role in addressing cellular dysfunction in cerebral blood vessels, glial cells, or neurons, as evidenced by bioassay measurements.
Career Highlights
Rudolf Kunze's career highlights include his tenure at Fresenius Medical Care Affina GmbH and the Max Delbrück Center for Molecular Medicine in Berlin-Buch. These institutions have provided him with a rich environment for research and development, allowing him to translate innovative ideas into actionable scientific advancements.
Collaborations
Throughout his career, Kunze has collaborated with esteemed colleagues, including Gerd Wallukat and Wolfgang Rönspeck. Such collaborations have fostered an exchange of knowledge and expertise, especially in the complex domain of molecular medicine, enhancing the potential impact of his inventions.
Conclusion
Rudolf Kunze's contributions through his patents signify a remarkable journey in innovation within the biomedical sector. His work not only reflects his expertise as an inventor but also the collaborative spirit of the scientific community in addressing complex medical challenges. The implications of his inventions could pave the way for new therapies, marking him as a vital figure in contemporary research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile